CAP-1002

In a Duchenne market beset by problems, Capricor data marks a bright spot
Pharma Voice
Mon, 08/5/24 - 11:04 am
Capricor
CAP-1002
deramiocel
DMD
5 DMD Data Readouts to Watch in 2024
BioSpace
Mon, 05/6/24 - 11:24 am
DMD
clinical trials
Pfizer
gene therapy
fordadistrogene movaparvovec
Dyne Therapeutics
DYNE-251
Edgewise Therapeutics
EDG-5506
Capricor
CAP-1002
Avidity Biosciences
AOC 1044
Duchenne muscular dystrophy: major trials and events to watch in 2023
Clinical Trials Arena
Thu, 03/16/23 - 09:49 am
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
Sarepta Therapeutics
SRP-9001
FibroGen
pamrevlumab
Capricor
CAP-1002
Santhera
ReveraGen
vamorolone
Capricor's DMD clinical trial meets primary endpoints
Endpoints
Fri, 09/24/21 - 11:52 am
Capricor
clinical trials
Duchenne Muscular Dystrophy
CAP-1002
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
Endpoints
Wed, 05/13/20 - 11:28 am
Capricor
stem cells
Duchenne Muscular Dystrophy
CAP-1002
Capricor: Can A Scarred Heart Be Repaired?
Seeking Alpha
Mon, 01/13/14 - 08:42 am
heart attacks
devices
CAP-1002
Capricor
Capricor gets $12.5M upfront payment in Janssen development agreement
Yahoo/Fly on the Wall
Sat, 01/4/14 - 04:16 pm
Capricor
Janssen
CAP-1002